To determine which miRNAs are possible targets for therapeutic targeting, we compared miRNA levels from CD8+PD1+ (exhausted) and CD8+PD-1− (non-exhausted) T cells isolated from mice-bearing 4T1 breast tumours. The gene discussed is CD8A; the disease is breast neoplasm.